The Mississippi River Delta is home to the world's largest contiguous swath of Phragmites australis, or more commonly known as the common reed. But the plant that can grow to nearly 20 feet tall and has been a critical component ...
The DNA of extinct species is providing a window into their biology, evolution, and natural history. However, after an animal's death, its DNA invariably breaks into tiny pieces, making it difficult to computationally reconstruct.
Researchers from the TU Delft have come up with a physical-based model that establishes a quantitative framework on how gene-editing with CRISPR-Cas9 works, and allows them to predict where, with what probability, and why ...
Ever since the movie Jurassic Park, the idea of bringing extinct animals back to life has captured the public's imagination—but what might scientists turn their attention towards first?
Malaria, a mosquito-borne disease, killed more than 620,000 people worldwide in 2020. Jeopardizing the survival of Plasmodium falciparum, the malaria parasite, is one way to control the spread of this deadly disease.
Dinosaurs went extinct 65 million years ago, mammoths 4,000 years ago, and the Christmas Island Rat 119 years ago. Since becoming a popular concept in the 1990s, de-extinction efforts have focused on grand animals with mythical ...
Stem cells can be used to study the effects of disease on numerous tissue types due to their pluripotency, or ability to produce cells of any type. But using gene-editing tools with them can be challenging, according to Xiaojun ...
They grow up to 12–15 feet tall and are causing havoc in the wetlands of North America. Known as Phragmites australis, the non-native common reed is one of the most important and most studied plants in the world.
One of the grand challenges with using CRISPR-based gene editing on humans is that the molecular machinery sometimes makes changes to the wrong section of a host's genome, creating the possibility that an attempt to repair ...
Recently, scientists from the University of Tsukuba developed a novel CRISPR/Cas9-based genome-editing tool called Target activation-induced cytidine deaminase (Target-AID). They targeted SlDELLA and SlETR in the model ...
